This HTML5 document contains 117 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q92561109
rdf:type
wikibase:Item
schema:description
scientific article published on 19 March 2019 wetenschappelijk artikel article scientifique publié en 2019 im März 2019 veröffentlichter wissenschaftlicher Artikel наукова стаття, опублікована 19 березня 2019 artículu científicu espublizáu en marzu de 2019
p:P577
wds:Q92561109-7A37E02A-B8D1-4B19-8883-E9A8F453FE6C
wdt:P577
2019-03-19T00:00:00Z
p:P2860
wds:Q92561109-C1A47A35-C5BF-48F0-A1A5-017EB243F0C2 wds:Q92561109-CC49F510-28CC-4C37-B208-AD46231A0178 wds:Q92561109-CDD5D659-80AC-49F5-82E5-79B4D20E7BE9 wds:Q92561109-ABB94F39-A038-4244-A612-F61FF716E096 wds:Q92561109-B0FB83C6-50A7-4F95-A288-C86808163738 wds:Q92561109-921A5677-E316-48BF-9CBC-7F5E3E6C6112 wds:Q92561109-9EC3B3D7-5EBD-4292-B824-755809FAF0C0 wds:Q92561109-A15EF501-4433-431E-B8BE-CA032A6D23C1 wds:Q92561109-7F198E6E-23DE-41BB-85A0-FD1DFE5EDD3E wds:Q92561109-8836C444-A58A-401A-9A95-37E21546353D wds:Q92561109-8A129F2E-5E56-4B1E-A10B-9F80EFFC62F7 wds:Q92561109-8BDF80FE-2126-48B2-B4CA-568D74C62B9F wds:Q92561109-793DC61F-56B2-4B56-BC8A-0F8E3AA38383 wds:Q92561109-7EE38D24-B4A7-4028-8698-1C3E4A4F64BD wds:Q92561109-58AEB1CF-9631-4FAB-AAE0-2B40A437A423 wds:Q92561109-6EEE5570-2A5C-42E5-8CF3-EB0E9BD5D4B1 wds:Q92561109-3B64C475-2B15-4B4C-B209-E81CCF542078 wds:Q92561109-3F673901-178C-46B1-8E18-7EFF2D94907D wds:Q92561109-40765986-09E6-432D-9FEF-EFEAA0E71E6E wds:Q92561109-41BF64A5-65F0-471F-8E20-AD880B068C6E wds:Q92561109-2E4103E3-881F-4965-9216-5F71BF9B8507 wds:Q92561109-309594B4-1788-46D4-A527-944AA78E1E4C wds:Q92561109-1B1A6514-73F0-4B28-94C1-7B9844B50021 wds:Q92561109-296CAA30-D87D-4E5F-93BB-4EB43FE01358 wds:Q92561109-2E278146-52DB-4F75-976D-A78708F7091C wds:Q92561109-0A3C9876-75AC-4168-A1BB-B7A0ACAAB35A wds:Q92561109-0DF46398-FADA-48FA-A91E-BA023619950C wds:Q92561109-15AEF1C0-248F-4119-A836-3AE3E02DE150 wds:Q92561109-16B39CDC-E744-4EA3-A39B-B985A93164AA wds:Q92561109-F81FA88C-185C-4138-A6FF-7CD12E549DA4 wds:Q92561109-ECD1ECC6-93F7-4CFC-9E5C-0677D78B701F wds:Q92561109-EEE11F10-052E-4754-8AA2-7F5A4EC8F314 wds:Q92561109-D2CBB1AA-4D2B-4E81-89EE-AFF952BB365E wds:Q92561109-E2CB36CA-F715-405C-A326-C9C3F4888A98 wds:Q92561109-E72632DD-891A-4D21-89C2-00DA920F856B wds:Q92561109-B983D133-60F8-46A6-9EA5-A63CAF362B6A
wdt:P2860
wd:Q50853249 wd:Q38851986 wd:Q50240328 wd:Q26799712 wd:Q34373867 wd:Q33880221 wd:Q37216235 wd:Q47589443 wd:Q38422152 wd:Q59356873 wd:Q41788281 wd:Q37410105 wd:Q30384060 wd:Q39570904 wd:Q46278917 wd:Q38961883 wd:Q38869669 wd:Q40265270 wd:Q28547717 wd:Q39043035 wd:Q36977388 wd:Q56829485 wd:Q47290558 wd:Q56521231 wd:Q38860221 wd:Q36141252 wd:Q38852471 wd:Q39109215 wd:Q38849814 wd:Q42285688 wd:Q39421000 wd:Q40971783 wd:Q46532772 wd:Q47258937 wd:Q40114254 wd:Q38741545
p:P2093
wds:Q92561109-014A43AD-5FF3-432E-A9A6-A461D02CFC62
wdt:P2093
Meg Doherty
rdfs:label
Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens
skos:prefLabel
Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens
schema:name
Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens
p:P50
wds:Q92561109-D6D4D7B7-E624-4C8E-84EF-1CA1047CBA0E wds:Q92561109-03D93037-3B2F-4C0F-AAEF-38E7C02D5923 wds:Q92561109-3B5B94F0-6ED4-43C3-B4C2-F7EBE8CA874C wds:Q92561109-98F6AA3B-B9DB-4D94-B305-285BA7526FD6 wds:Q92561109-AC489B29-88CF-4DA8-AB97-95EF8EF67990
wdt:P50
wd:Q62750853 wd:Q96102518 wd:Q114437792 wd:Q101823445 wd:Q57904764
p:P1476
wds:Q92561109-6D15F4A2-A129-44AB-BB49-B40EA36F2D7F
wdt:P1476
Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens
p:P304
wds:Q92561109-74B56025-BA25-4E13-9240-00F30D16EE66
wdt:P304
e246-e252
p:P31
wds:Q92561109-EBB34828-140F-4D33-9907-516576C95A26
wdt:P31
wd:Q13442814
p:P698
wds:Q92561109-19F4AB2F-A742-4431-90B4-FF828904E1D1
wdtn:P698
n12:30902440
wdt:P698
30902440
p:P1433
wds:Q92561109-371F8069-A750-44CE-9EAC-C43813607425
wdt:P1433
wd:Q15724248
p:P433
wds:Q92561109-EB09B8E4-036C-4414-9E36-4E4D5C1A00D8
p:P478
wds:Q92561109-B47CC24C-CF2E-483E-B3A0-598D72E265BF
wdt:P433
7
wdt:P478
19
p:P356
wds:Q92561109-68179B74-4518-47D3-88B1-DF9245C278E6
wdtn:P356
n11:S1473-3099(18)30710-2
wdt:P356
10.1016/S1473-3099(18)30710-2